
Teens Risk Severe Harm in 'Heightmaxxing' Trend Using Black-Market Cancer Drug
Medical experts warn that a social media trend called 'heightmaxxing' is driving teenagers to take erdafitinib, a prescription cancer drug, to increase their height. While some teens report growth, doctors emphasize that the drug is unapproved for this use and causes severe side effects, including vision damage and skeletal fractures. Johnson & Johnson confirmed the medication has no established safety profile for adolescents.









